Vaccines
Conditions
Interventions
Infants allocated to Intervention Group 1 (IG1) will undergo the breastfeeding process before vaccination. Mothers will be asked, still in the private room and in a comfortable chair, to breastfeed th
2. Mouth wide open
3. Lower lip turned out
4. Chin touching breast. Swallowing (visible and/or audible) will also be identified (BRASIL, 2015). Then, mothers will be instructed to stop breastfeeding during the entire vaccination procedure.
Inf
Sponsors
Universidade Federal do Piauí - Campus Amílcar Ferreira Sobral
Universidade Federal do Piauí - Campus Amílcar Ferreira Sobral
Eligibility
Age
60 Days to 89 Days
Inclusion criteria
Inclusion criteria: Infants aged between 60 and 89 days; who are breastfed; who were born with a gestational age of 37-42 weeks; no visible and/or reported congenital malformations by the mother; in need of Pentavalent vaccination.
Exclusion criteria
Exclusion criteria: Infants who are not breastfed directly from the breast; who have used analgesics in the last 48 hours before vaccination; who are agitated before vaccination; who have a history of hypersensitivity to any component of the immunobiological and/or other contraindications established by the Ministry of Health (BRASIL, 2016); or develop an allergic reaction such as a rash to the vaccine given.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to find a reduction in pain associated with the administration of the Pentavalent vaccine in 2-month-old infants, verified by the use of breastfeeding before and during the vaccination procedure, from the observation of a variation of at least 2.3 points in the measurements of pain between the intervention and control groups, assessed by the FLACC Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are not expected. | — |
Countries
Brazil
Contacts
Public ContactMaria Bezerra
Universidade Federal do Piauí
Outcome results
None listed